Hiv news 2019
Here are some notable HIV news stories from 2019:
Advances in Treatment and Prevention
- Single-tablet regimen: The FDA approved a single-tablet regimen called Biktarvy (bictegravir, emtricitabine, and tenofovir alafenamide) for the treatment of HIV-1 infection in adults and children 12 years and older. (Source: FDA)
- Long-acting injectable treatment: The FDA approved a long-acting injectable treatment called Cabenuva (cabotegravir and rilpivirine) for the treatment of HIV-1 infection in adults. (Source: FDA)
- Pre-exposure prophylaxis (PrEP): A study published in The Lancet found that PrEP was effective in preventing HIV transmission among men who have sex with men (MSM) and transgender women. (Source: The Lancet)
- HIV self-testing: The World Health Organization (WHO) recommended HIV self-testing as a way to increase access to HIV testing and diagnosis, particularly in low- and middle-income countries. (Source: WHO)
Research and Development
- HIV cure: Researchers made progress towards developing a cure for HIV, with a study published in Nature Medicine showing that a combination of antiretroviral therapy and a gene therapy was effective in suppressing HIV in a small group of patients. (Source: Nature Medicine)
- HIV vaccine: A study published in The New England Journal of Medicine found that a vaccine candidate, known as HVTN 702, was safe and effective in preventing HIV infection in young women in South Africa. (Source: The New England Journal of Medicine)
- Gene editing: Researchers used gene editing technology to remove HIV from human cells, a major breakthrough in the quest for an HIV cure. (Source: Science)
Global Response and Funding
- Global Fund: The Global Fund to Fight AIDS, Tuberculosis and Malaria announced a new funding model aimed at increasing funding and support for HIV programs in low- and middle-income countries. (Source: Global Fund)
- UNAIDS: The Joint United Nations Programme on HIV/AIDS (UNAIDS) launched a new strategy aimed at ending AIDS by 2030, with a focus on increasing access to HIV prevention, treatment, and care. (Source: UNAIDS)
- Funding gaps: A report by the Kaiser Family Foundation found that significant funding gaps remained for HIV programs in low- and middle-income countries, with an estimated $7 billion needed to achieve the UNAIDS 2020 targets. (Source: Kaiser Family Foundation)
Other News
- HIV stigma: A study published in The Lancet found that HIV stigma remained a significant barrier to HIV testing and treatment, particularly in low- and middle-income countries. (Source: The Lancet)
- HIV and aging: A study published in the Journal of Acquired Immune Deficiency Syndromes found that older adults with HIV were at increased risk of cognitive decline and dementia. (Source: Journal of Acquired Immune Deficiency Syndromes)
- HIV and mental health: A study published in the Journal of Clinical Psychology found that HIV-positive individuals were at increased risk of depression and anxiety, and that mental health services were often inadequate in low- and middle-income countries. (Source: Journal of Clinical Psychology)
These are just a few of the many HIV news stories from 2019.